Overview

Observational Study in Type 2 Diabetics Failing on Oral Antidiabetic Therapy and Starting on Insulin Treatment

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe. The aim of this observational study is to evaluate glycaemic control in subjects with type 2 diabetes using once daily LevemirĀ® as initiation of insulin therapy in Hungary.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Hypoglycemic Agents
Insulin
Insulin Detemir
Insulin, Globin Zinc